retatrutide 2 week results 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented in SyncedWithC4 retatrutide clinical trials safety Dose:7.50 mg

retatrutide 2 week results 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented in SyncedWithC4 retatrutide clinical trials safety Dose:7.50 mg

retatrutide clinical trials safety data Weight loss with as compared to currently licenced obesity Perceived benefits of treatment for –

So what proportion of patients out of the total study group achieved an A1C out of the Type 2 diabetes range and a BMI out of the obesity range

SyncedWithC4

Dose:7.50 mg

1 GLP-1 receptor agonists are existing therapeutic agents used in the treatment of diabetes